Home-based zoledronic acid infusion therapy in patients with solid tumours: Compliance and patient-nurse satisfaction

Supportive Care in Cancer

Volumn 21, Issue 6, 2013, Pages 1613-1620

  Lebret, Thierry ^a   Mouysset, Jean Loup ^b   Lortholary, Alain ^c   El Kouri, Claude ^c   Bastit, Laurent ^d   Ktiouet, Meryem ^e   Slimane, Khemaies ^e   Murraciole, Xavier ^f   Guérif, Stéphane ^g  

^a LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

^b Polyclinique du Parc Rambot   (France)

^c Centre Catherine de Sienne   (France)

^d Centre de Radiothérapie   (France)

^e NOVARTIS PHARMA K K   (Japan)

^f TIMONE HOSPITAL   (France)

^g POITIERS UNIVERSITY HOSPITAL   (France)

Author keywords

Bisphosphonate; Compliance; Nurse satisfaction; Patient satisfaction; Zoledronic acid

Indexed keywords

CALCIUM; VITAMIN D; ZOLEDRONIC ACID;

ADULT; AGED; ARTICLE; BENIGN TUMOR; BONE METASTASIS; BREAST CANCER; BREAST DISEASE; CLINICAL TRIAL; CONNECTIVE TISSUE DISEASE; CREATININE CLEARANCE; CYST; DOCTOR PATIENT RELATION; DRUG SUBSTITUTION; DRUG TOLERABILITY; DRUG WITHDRAWAL; EAR DISEASE; EYE DISEASE; FEMALE; FLU LIKE SYNDROME; FRACTURE; GASTROINTESTINAL DISEASE; GENITAL SYSTEM DISEASE; HEART DISEASE; HEMATOLOGIC DISEASE; HEPATOBILIARY DISEASE; HOME ENVIRONMENT; HUMAN; HYDRATION; IMMUNOPATHOLOGY; INFECTION; INFESTATION; INFUSION; INNER EAR DISEASE; JAW OSTEONECROSIS; KIDNEY DISEASE; LUNG CANCER; LYMPHATIC SYSTEM DISEASE; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MEDIASTINUM DISEASE; MENTAL DISEASE; METABOLIC DISORDER; MOUTH HYGIENE; MUSCULOSKELETAL DISEASE; NEUROLOGIC DISEASE; NURSE SATISFACTION; NUTRITIONAL DISORDER; PATIENT SATISFACTION; POLYP; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE CANCER; PROTOCOL COMPLIANCE; RESPIRATORY TRACT DISEASE; SATISFACTION; SIDE EFFECT; SKIN DISEASE; SOLID TUMOR; THORAX DISEASE; TOOTH ABSCESS; URINARY TRACT DISEASE; VASCULAR DISEASE;

ADULT; AGED; AGED, 80 AND OVER; ATTITUDE OF HEALTH PERSONNEL; BONE DENSITY CONSERVATION AGENTS; BONE NEOPLASMS; BREAST NEOPLASMS; DIPHOSPHONATES; FEASIBILITY STUDIES; FEMALE; FRACTURES, BONE; HOME INFUSION THERAPY; HUMANS; IMIDAZOLES; LONGITUDINAL STUDIES; LUNG NEOPLASMS; MALE; MIDDLE AGED; NURSES, COMMUNITY HEALTH; OSTEONECROSIS; PATIENT COMPLIANCE; PATIENT SATISFACTION; PHYSICIANS; PROSPECTIVE STUDIES; PROSTATIC NEOPLASMS;

EID: 84879148394     PISSN: 09414355     EISSN: 14337339     Source Type: Journal    
DOI: 10.1007/s00520-012-1705-3     Document Type: Article

References (18)

1. Coleman R (2011) The use of bisphosphonates in cancer treatment. Ann N Y Acad Sci 1218:3-14. doi: 10.1111/j.1749-6632.2010.05766.x
2. Joerger M, Gnant M (eds) (2012) Prevention of bone metastases. Recent Results Cancer Res Ser 192. doi: 10.1007/978-3-642-21892-7
3. Coleman R, Cook R, Hirsh V, Major P, Lipton A (2011) Zoledronic acid use in cancer patients: more than just supportive care? Cancer 117:11-23
4. Berenson JR (2011) Antitumor effects of bisphosphonates: from the laboratory to the clinic. Curr Opin Support Palliat Care 5:233-240
5. Lipton A (2011) Zoledronic acid: multiplicity of use across the cancer continuum. Expert Rev Anticancer Ther 11:999-1012
6. Wong MH, Stockler MR, Pavlakis N (2012) Bisphosphonates and other bone agents for breast cancer. Cochrane Database Syst Rev 2:CD003474
7. Yan T, Yin W, Zhou Q, Zhou L, Jiang Y, Du Y, Shao Z, Lu J (2012) The efficacy of zoledronic acid in breast cancer adjuvant therapy: a meta-analysis of randomised controlled trials. Eur J Cancer 48:187-195
8. Chern B, Joseph D, Joshua D, Pittman K, Richardson G, Schou M, Lowe S, Copeman M, De Abreu LR, Lynch K (2004) Bisphosphonate infusions: patient preference, safety and clinic use. Support Care Cancer 12:463-466
9. Marr HK, Stiles CR, Boyar MA, Braun TC, Hagen NA, Janzen C, Whitten LM, Pereira JL (2010) Feasibility of administering zoledronic acid in palliative patients being cared for in the community: results of a pilot study. Curr Oncol 17:69-74
10. Wardley A, Davidson N, Barrett-Lee P, Hong A, Mansi J, Dodwell D, Murphy R, Mason T, Cameron D (2005) Zoledronic acid significantly improves pain scores and quality of life in breast cancer patients with bone metastases: a randomised, crossover study of community vs hospital bisphosphonate administration. Br J Cancer 92:1869-1876
11. Italiano A, Ciais C, Chamorey E, Marcy PY, Largillier R, Ferrero JM, Thyss A (2006) Home infusions of biphosphonate in cancer patients: a prospective study. J Chemother 18:217-220
12. Santangelo A, Testai M, Barbagallo P, Manuele S, Di Stefano A, Tomarchio M, Trizzino G, Musumeci G, Panebianco P, Maugeri D (2006) The use of bisphosphonates in palliative treatment of bone metastases in a terminally ill, oncological elderly population. Arch Gerontol Geriatr 43:187-192
13. Tassinari D, Poggi B, Nicoletti S, Fantini M, Tamburini E, Possenti C, Sartori S (2007) Zoledronic acid treatment at home: safety data from an observational prospective trial. J Palliat Med 10:352-358
14. Quesnel M (2007) Nurse's role in the home management of patients with breast cancer and bone metastases. Soins 715:26-28
15. Coleman R, Burkinshaw R, Winter M, Neville-Webbe H, Lester J, Woodward E, Brown J (2011) Zoledronic acid. Expert Opin Drug Saf 10:133-145
16. Khan AA, Rios LP, Sãndor GK, Khan N, Peters E, Rahman MO, Clokie CM, Dore E, Dubois S (2011) Bisphosphonate-associated osteonecrosis of the jaw in Ontario: a survey of oral and maxillofacial surgeons. J Rheumatol 38:1396-1402
17. Barrett-Lee P, Bloomfield D, Dougherty L, Harries M, Laing R, Patel H, Walker M (2007) An audit to determine the time taken to administer intravenous bisphosphonate infusions in patients diagnosed with metastatic breast cancer to bone in a hospital setting. Curr Med Res Opin 23:1575-1582
18. Jensen BT, Dielenseger P, Drudge-Coates L, Flynn K, Hieronymi S, Erik van Muilekom HA, Pieters R, Voss LB (2012) Taking the lead: sharing best practice in intravenous bisphosphonate use in urological cancers. Eur J Oncol Nurs 16:42-53. doi: 10.1016/j.ejon.2011.02.006